BR0304956A - Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável - Google Patents

Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável

Info

Publication number
BR0304956A
BR0304956A BR0304956-6A BR0304956A BR0304956A BR 0304956 A BR0304956 A BR 0304956A BR 0304956 A BR0304956 A BR 0304956A BR 0304956 A BR0304956 A BR 0304956A
Authority
BR
Brazil
Prior art keywords
hypertension
coronary insufficiency
form useful
chronic stable
stable coronary
Prior art date
Application number
BR0304956-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Omilton Visconde Jr
Original Assignee
Laboratorios Biosintetica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Biosintetica Ltda filed Critical Laboratorios Biosintetica Ltda
Priority to BR0304956-6A priority Critical patent/BR0304956A/pt
Priority to ECSP045478 priority patent/ECSP045478A/es
Priority to CO04123478A priority patent/CO5650066A1/es
Priority to PE2004001213A priority patent/PE20050901A1/es
Priority to MXPA04012380 priority patent/MXPA04012380A/es
Priority to ARP040104581 priority patent/AR046876A1/es
Publication of BR0304956A publication Critical patent/BR0304956A/pt

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0304956-6A 2003-12-09 2003-12-09 Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável BR0304956A (pt)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BR0304956-6A BR0304956A (pt) 2003-12-09 2003-12-09 Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável
ECSP045478 ECSP045478A (es) 2003-12-09 2004-12-08 Combinación farmacéutica en una nueva forma farmaceutica útil en la hipertensión arterial y en la insuficiencia coronaria estable.
CO04123478A CO5650066A1 (es) 2003-12-09 2004-12-09 Combinacion farmaceutica en una nueva forma farmaceutica util en la hipertension arterial y en la insuficiencia coronaria estable
PE2004001213A PE20050901A1 (es) 2003-12-09 2004-12-09 Combinacion de amlodipina y atenolol bajo la forma farmaceutica de capsula
MXPA04012380 MXPA04012380A (es) 2003-12-09 2004-12-09 Combinacion farmaceutica en una nueva forma farmaceutica util en la hipertension arterial y en la insuficiencia coronaria cronica estable.
ARP040104581 AR046876A1 (es) 2003-12-09 2004-12-09 Asociacion farmaceutica en una forma farmaceutica util en la hipertension arterial y en la insuficiencia coronaria cronica estable

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0304956-6A BR0304956A (pt) 2003-12-09 2003-12-09 Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável

Publications (1)

Publication Number Publication Date
BR0304956A true BR0304956A (pt) 2005-11-08

Family

ID=35295191

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0304956-6A BR0304956A (pt) 2003-12-09 2003-12-09 Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável

Country Status (6)

Country Link
AR (1) AR046876A1 (es)
BR (1) BR0304956A (es)
CO (1) CO5650066A1 (es)
EC (1) ECSP045478A (es)
MX (1) MXPA04012380A (es)
PE (1) PE20050901A1 (es)

Also Published As

Publication number Publication date
CO5650066A1 (es) 2006-06-30
AR046876A1 (es) 2005-12-28
ECSP045478A (es) 2006-09-18
MXPA04012380A (es) 2005-10-19
PE20050901A1 (es) 2005-12-16

Similar Documents

Publication Publication Date Title
NO20051688D0 (no) Farmasoytiske blandinger som har en modifisert baerer
NO20052739D0 (no) CCR5-antagonister som medikamenter
NO20050115D0 (no) Datamaskinnavigering
ATE485835T1 (de) Antikörper enthaltende pharmazeutische lösungen
ATE223719T1 (de) Schnellauflösende efavirenz-kapseln oder tabletten durch verwendung von super-zersetzern
CY1112582T1 (el) Διαδερμικη χορηγηση φεντανυλης
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
EA200401515A1 (ru) Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а
FI20021310A (fi) Jauhin
DE602004030346D1 (de) Gelatinkapseln
PL1941263T3 (pl) Optyczna półilościowa 100% kontrola napełniania kapsułek farmaceutycznych na maszynach do napełniania kapsułek
DK1694311T3 (da) Tyggelige bløde kapsler indeholdende ugelatineret stivelse
DE60021609D1 (de) Pharmazeutische Zusammensetzung enthaltend einen Metabolit von Buspirone
BR0304956A (pt) Combinação farmacêutica em uma nova forma farmacêutica útil na hipertensão arterial e na insuficiência coronariana crÈnica estável
ATE332690T1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE502004010073D1 (de) Doppelseitiger tourbillon
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
ITRM20050521A1 (it) Composizione a base di vitamine k e d per la prevenzione e il trattamento dell'osteoporosi.
DE60328787D1 (de) Pharmazeutische salze von reboxetin
IS7581A (is) Lyfjasamsetning
DE60217369D1 (de) Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain
BRPI0415428A (pt) formulações terapêuticas
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
ITMI20030826A1 (it) Composizione farmaceutica contenente interferone per il

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: BASEADO NO ART. 216 1 DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO PARA QUE ESTA SEJA ACEITA.

B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADO DE: LABORATORIOS BIOSINTETICA LTDA

B25G Requested change of headquarter approved

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 018050004541/SP DE 18/07/2005.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25M Entry on limitation or onus of patent assignment [chapter 25.13 patent gazette]

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: REF: PROC. INPI NO 52400031036/2012-78 E PROCESSO DE ARROLAMENTO DE BENS DA SECRETARIA DA RECEITA FEDERAL SP NO 16643.720002/2011-54 ANOTADO O ARROLAMENTO DO PEDIDO DE PATENTE EM EPIGRAFE, CONFORME DETERMINACAO DA SECRETARIA DA RECEITA FEDERAL DO ESTADO DE SAO PAULO, NOS TERMOS DO 5O, DO ART. 64 DA LEI NO 9.532/97.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.